Previous studies have linked CXCL16 and its receptor CXCR6 to inflammation-associated cancers [52], renal fibrosis [53], and vascular inflammatory diseases, such as atherosclerosis [54]. The gene discussed is CXCR6; the disease is renal fibrosis.